BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 24879097)

  • 1. Heterogeneity in the differentiation and function of CD8⁺ T cells.
    Mittrücker HW; Visekruna A; Huber M
    Arch Immunol Ther Exp (Warsz); 2014 Dec; 62(6):449-58. PubMed ID: 24879097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
    Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
    J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
    Tajima M; Wakita D; Satoh T; Kitamura H; Nishimura T
    Int Immunol; 2011 Dec; 23(12):751-9. PubMed ID: 22039016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
    Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
    Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines.
    Cerwenka A; Carter LL; Reome JB; Swain SL; Dutton RW
    J Immunol; 1998 Jul; 161(1):97-105. PubMed ID: 9647212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tc9 cells, a new subset of CD8(+) T cells, support Th2-mediated airway inflammation.
    Visekruna A; Ritter J; Scholz T; Campos L; Guralnik A; Poncette L; Raifer H; Hagner S; Garn H; Staudt V; Bopp T; Reuter S; Taube C; Loser K; Huber M
    Eur J Immunol; 2013 Mar; 43(3):606-18. PubMed ID: 23254356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells.
    Fenoglio D; Ferrera F; Fravega M; Balestra P; Battaglia F; Proietti M; Andrei C; Olive D; Antonio LC; Indiveri F; Filaci G
    Hum Immunol; 2008 Nov; 69(11):745-50. PubMed ID: 18832002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD73-mediated adenosine production promotes stem cell-like properties in mouse Tc17 cells.
    Flores-Santibáñez F; Fernández D; Meza D; Tejón G; Vargas L; Varela-Nallar L; Arredondo S; Guixé V; Rosemblatt M; Bono MR; Sauma D
    Immunology; 2015 Dec; 146(4):582-94. PubMed ID: 26331349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence or absence of TGF-beta determines IL-4-induced generation of type 1 or type 2 CD8 T cell subsets.
    Erard F; Garcia-Sanz JA; Moriggl R; Wild MT
    J Immunol; 1999 Jan; 162(1):209-14. PubMed ID: 9886388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression and costimulatory effect of 4-1BB (CD137) and CD28 molecules on cytokine-induced murine CD8(+) Tc1 and Tc2 cells.
    Vinay DS; Kwon BS
    Cell Immunol; 1999 Feb; 192(1):63-71. PubMed ID: 10066348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression.
    Faghih Z; Rezaeifard S; Safaei A; Ghaderi A; Erfani N
    Iran J Immunol; 2013 Dec; 10(4):193-204. PubMed ID: 24375061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 1999 Jun; 162(11):6671-80. PubMed ID: 10352285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
    Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
    Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functions of CD8 T-cell subsets secreting different cytokine patterns.
    Mosmann TR; Li L; Sad S
    Semin Immunol; 1997 Apr; 9(2):87-92. PubMed ID: 9194219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
    Okamoto I; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
    J Immunol; 1999 Mar; 162(6):3202-11. PubMed ID: 10092771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17+ CD8+ T cells: Differentiation, phenotype and role in inflammatory disease.
    Srenathan U; Steel K; Taams LS
    Immunol Lett; 2016 Oct; 178():20-6. PubMed ID: 27173097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
    Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
    Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Committed memory effector type 2 cytotoxic T (Tc2) cells are ineffective in protective anti-tumor immunity.
    Do JS; Choi YH; Shin SH; Yi HK; Hwang PH; Nam SY
    Immunol Lett; 2004 Aug; 95(1):77-84. PubMed ID: 15325801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decisions on the road to memory.
    Amsen D; Backer RA; Helbig C
    Adv Exp Med Biol; 2013; 785():107-20. PubMed ID: 23456843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.